Search results
Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows - ET HealthWorld
The Economic Times· 1 day agoGLP-1 treatments for type 2 diabetes have been on the market for nearly 20 years. The newer...
Every 3rd Indian affected by fatty liver disease: Minister Jitendra Singh
Business Standard India· 2 days agoFatty liver disease: Union Minister of Science and Technology launches the Indo-French Liver and...
Rising cases of Breast cancer: Everything you need to know so far
Business Standard India· 2 days agoBreast cancer is a rising health concern for women in both rural and urban areas of India. This type...
Highly contagious African Swine Fever reported in Kerala's Thrissur
Business Standard India· 2 days agoAn outbreak of African Swine Fever, a highly contagious and deadly swine disease that can affect...
Lupin Summary: Latest Updates and Details | India Infoline
India Infoline· 2 days agoLupin Ltd Summary: Check out the latest management information and corporate updates of Lupin at India Infoline
Pentixapham acquires antibody discovery business of Glycotope
Pharmaceutical Technology· 3 days agoRadiopharmaceuticals have been an area of interest in the past few years, attracting significant...
FDA approves Eli Lilly’s Kisunla (donanemab) for early AD
Pharmaceutical Technology· 3 days agoEli Lilly announced on 2 July 2024 that the US Food and Drug Administration (FDA) has approved its...
What is the brain-eating amoeba behind the recent deaths in Kerala?
Business Standard India· 3 days agoA 14-year-old boy undergoing treatment for primary amoebic meningoencephalitis, a rare infection...
With four more bridge collapses in a day, Bihar tally touches 10 in 2 weeks
Business Standard India· 3 days agoThe bridges that gave way were in Damdaspurpur, Patera, Dhamai villages and Sikandarpur. This...
Eli Lilly's popular drug Mounjaro stuck at Indian regulators' counter
Business Standard India· 3 days agoPharmaceutical firm Eli Lilly is still awaiting approval from India’s drug regulator to market its...